BusinessIndustryReports has recently broadcasted a new study to its broad research portfolio, which is titled as “Global CRISPR Market” Research Report 2019 provides an in-depth analysis of the CRISPR with the forecast of market size and growth. The analysis includes addressable market, market by volume, market share by business type and by segment (external and in-house). The research study examines the CRISPR on the basis of a number of criteria, such as the product type, application, and its geographical presence.
The Global CRISPR Market to reach $6 Billion by 2025. The Global CRISPR Market is valued at approximately $248 Million in 2015.
The growth is primarily driven by the rising demand for drug discovery and a significant rise in research spending. Further, increasing prevalence of genetic disorders due to late pregnancies and changing lifestyle patterns have drawn the significant attention of the researchers towards this emerging technology.
The Global CRISPR Market is segmented on the basis of Application, End-User and Region. CRISPR market is cover distinctive segment market estimate, both volume and value, also cover diverse businesses customers’ data, which is imperative for the makers.
Based on the Application, the Global CRISPR Market is sub-segmented into Genome Editing, Genetic Engineering, Gene Library, CRISPR Plasmid, Human Stem Cells, Genetically Modified Crops (GMO), Cell Line Engineering and others. On the basis of Application, the Global CRISPR Market is classified into Biotechnology Companies, Pharmaceutical Companies, Academic Institutes, Research & Development Institutes and others.
In terms of geographic analysis, the global market is dominated by the North America region followed by the Asia Pacific. The rising prevalence of infertility and genetic disorders in the Asia Pacific region are the primary driving factors. Agriculture and Animal breeding are emerging applications in Asian countries. North America captures approximately 38% of the total revenue share in 2015. Europe is also an emerging region for the development of this technology.
Latest Industry News:
Thermo Fisher Scientific (November 22, 2019) – Thermo Fisher Scientific Unveils $6 Million Expansion at Viral Vector Manufacturing Facility – Thermo Fisher Scientific, the world leader in serving science, today unveiled the $6 million expansion of its gene therapy and viral vector services site in Alachua, Florida. The investment doubles the site’s laboratory and warehousing capacity for upstream process development and quality control testing of gene therapy products.
The expansion at the Alachua facility is part of Thermo Fisher’s $270 million investment this year to expand its capabilities, capacity and talent globally to enable its customers to develop and deliver high quality medicines to patients around the world. This investment follows the company’s recent acquisition of Brammer Bio, a leader in viral vector manufacturing.
“The team at our Alachua site has more than12 years of expertise developing processes, analytics and manufacturing GMP materials to help our customers with clinical development of advanced medicines for rare and complex diseases,” said Chris Murphy, vice president and general manager, viral vector services at Thermo Fisher. “This investment in Alachua signifies our continued commitment to serve our gene therapy customers and their patients in need.”
“Thermo Fisher’s investment to expand here in Alachua highlights our reputation as a destination for the biotech industry,” said Eric Godet, CEO of the Greater Gainesville Chamber of Commerce. “As the company continues to grow to serve their customers around the globe with medical advancements, so do the economic and workforce opportunities for our community.”
Purchase this report online with 120 Pages, List of Tables & Figures and in-depth Table of Contents on “Global CRISPR Market Report 2019” @ www.businessindustryreports.com/buy-now/103619/single .
Top Leading Key in Players Global CRISPR Market:
Thermo Fisher Scientific, Editas Medicine, Caribou Biosciences, CRISPR Therapeutics A, Intellia Therapeutics, Cellectis, Horizon Discovery, Sigma-Aldrich Corp, Precision BioSciences, GenScript Corp, Sangamo Therapeutics, Lonza Group, Integrated DNA Technologies, New England Biolabs, OriGene Technologies, Transposagen Biopharmaceuticals and others. New product launches and continuous technological innovations are the key strategies adopted by the major players.
With the presence of a large pool of participants, the Global CRISPR Market is displaying a highly competitive business landscape, finds a new research report by Business Industry Reports (BIR). Thermo Fisher Scientific, Editas Medicine, Caribou Biosciences, CRISPR Therapeutics A, Intellia Therapeutics, Cellectis are some of the key vendors of CRISPR across the world. These players across CRISPR Market are focusing aggressively on innovation, as well as on including advanced technologies in their existing products.
Region segment: CRISPR Market report is segmented into several key regions, with sales, revenue, market share (%) and growth Rate (%) of CRISPR in these regions, from 2013 to 2025 (forecast), covering: North America, Europe, Asia Pacific, Middle East & Africa and South America
Major Points in Table of Contents:
Global CRISPR Market Report 2019
1 Research Methodology
2 Global CRISPR Market Definition & Scope
3 Executive Summary
4 Global CRISPR Industry Dynamics
5 Global CRISPR Market by Application
6 Global CRISPR Market by End User
7 Global CRISPR Market, Regional Analysis
8 Competitive Intelligence
BusinessindustryReports.com is a digital database of comprehensive market reports for global industries. As a market research company, we take pride in equipping our clients with insights and data that holds the power to truly make a difference to their business. Our mission is singular and well-defined – we want to help our clients envisage their business environment so that they are able to make informed, strategic and therefore successful decisions for themselves.
Business Industry Reports
Pune – India